Who is sponsoring NCT06979414?

NCT06979414 is sponsored by Yakup Akyüz.

What drugs are being tested in NCT06979414?

Interventions in NCT06979414: Nurse-led Transfer Programme with Family Involvement.

What condition does NCT06979414 study?

NCT06979414 studies Transfer Anxiety, Intensive Care Unit Discharge, Cardiac Surgery Recovery, Postoperative Anxiety, Critical Care Transition.

Is NCT06979414 still recruiting?

NCT06979414 is currently completed. Last updated 19 May 2025.

Last reviewed 2025-05-19 · How we verify

NCT06979414: FICARE-TX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nurse-Led Transfer Program With Family Involvement to Reduce ICU Patient Anxiety

Completed NA Last updated 19 May 2025

What this trial tests

NA trial testing Nurse-led Transfer Programme with Family Involvement in Transfer Anxiety in 150 participants. Completed in 31 January 2025.

Timeline

1 August 2024

Primary endpoint
30 October 2024

31 January 2025

Quick facts

Lead sponsor	Yakup Akyüz
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	150
Start date	1 August 2024
Primary completion	30 October 2024
Estimated completion	31 January 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Nurse-led Transfer Programme with Family Involvement

Conditions studied

Transfer Anxiety — all drugs for Transfer Anxiety →
Intensive Care Unit Discharge — all drugs for Intensive Care Unit Discharge →
Cardiac Surgery Recovery — all drugs for Cardiac Surgery Recovery →
Postoperative Anxiety — all drugs for Postoperative Anxiety →

Sponsor

Yakup Akyüz

Who can join

18 and older, any sex, with Transfer Anxiety or Intensive Care Unit Discharge. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate whether including a patient's family member during transfer from the intensive care unit (ICU) to the general ward can help reduce anxiety in patients who have undergone cardiovascular surgery. The research is being conducted in a cardiovascular ICU in Turkey. Patients in the intervention group are accompanied by a close relative during the transfer process. Their anxiety levels and vital signs are measured before and after the transfer and compared to those of patients transferred without a relative.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Nurse-Led Transfer Programme With Patient Relatives: Effect on Reducing Transfer Anxiety in Intensive Care Unit Patients.
Akyüz Y, Er S, Bozok Ş, Uslu Y. · · 2025 · PMID 40919712 · DOI 10.1111/nicc.70153

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06979414 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yakup Akyüz
Last refreshed: 19 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06979414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing